Inventor
Adel M. Moussa
Inventor
Burlington, MA, US
Overview
Patents· 48 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations26%
C07HSugars22%
A61KPreparations for medical, dental or toiletry purposes20%
C07DHeterocyclic compounds12%
C07CAcyclic or carbocyclic compounds7%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium5%
Y02PClimate change mitigation technologies in the production or processing of goods3%
C07BGeneral methods of organic chemistry2%
B01DSeparation1%
C08KUse of inorganic or non-macromolecular organic substances as compounding ingredients1%
PatentTitleYear
10,874,687Highly active compounds against COVID-19202010,875,885b-d-2'-deoxy-2'-a-fluoro-2'-b-c-substituted-2-modified-n202010,870,672b-D-2'-deoxy-2'-a-fluoro-2'-b-C-substituted-2-modified-N6-substituted purine nucleotides for HCV treatment202010,870,673b-D-2'-deoxy-2'-a-fluoro-2'-b-C-substituted-2-modified-N202010,815,266b-D-2'-deoxy-2'-a-fluoro-2'-b-C-substituted-2-modified-N202010,723,7542',4'-bridged nucleosides for HCV infection202010,717,758D-amino acid compounds for liver disease202010,711,029Beta-d-2'-deoxy-2'-alpha-fluoro-2'-beta-c-substituted-4'fluoro-n6-substituted-6-amino-2-substituted purine nucleotides for the treatment of hepatitis c virus infection202010,683,3214'-or nucleosides for the treatment of HCV202010,519,186Nucleotide hemi-sulfate salt for the treatment of hepatitis C virus201910,513,5342'-chloro nucleoside analogs for HCV infection201910,251,903Process for making nucleoside phosphoramidate compounds201910,239,911Beta-D-2'-deoxy-2'-alpha-fluoro-2'-beta-C-substituted-2-modified-N6-substituted purine nucleotides for HCV treatment201910,238,680D-amino acid phosphoramidate pronucleotides of halogeno pyrimidine compounds for liver disease201910,231,986Amino acid phosphoramidate pronucleotides of 2'-cyano, azido and amino nucleosides for the treatment of HCV201910,202,412b-D-2'-deoxy-2'-substituted-4'-substituted-2-substituted-N201910,005,811b-D-2'-deoxy-2'-a-fluoro-2'b-C-substituted-2-modified-N201810,000,523b-D-2'-deoxy-2'-a-fluoro-2'-b-C-substituted-2-modified-N20189,828,410b-D-2'-deoxy-2'-a-fluoro-2'-b-C-substituted-2-modified-N20179,339,541'Thiophosphate nucleosides for the treatment of HCV'20169,309,275'3′-deoxy nucleosides for the treatment of HCV'20169,211,300'4′-fluoro nucleosides for the treatment of HCV'20159,192,621'Esters and malonates of SATE prodrugs'20159,187,515'2′,4′-fluoro nucleosides for the treatment of HCV'20159,109,001'3′,5′-cyclic phosphoramidate prodrugs for HCV infection'20158,486,991'Enantiomerically pure phosphoindoles as HIV inhibitors'20138,470,870'Solid forms of an anti-HIV phosphoindole compound'20138,093,379'Macrocyclic serine protease inhibitors'20127,960,428'Enantiomerically pure phosphoindoles as HIV inhibitors'20117,781,576'Process for preparing a synthetic intermediate for preparation of branched nucleosides'20107,598,373'Process for the production of 2-C-methyl-D-ribonolactone'20097,595,390'Industrially scalable nucleoside synthesis'20097,531,573'Use of triaryl methane compounds for inhibiting unwanted cellular proliferation associated with inflammatory disease'20097,365,090'Substituted phenylindoles for the treatment of HIV'20087,342,038'Substituted diphenyl indanone, indane and indole compounds and analogues thereof useful for the treatment or prevention of diseases characterized by abnormal cell proliferation'20086,992,079'Substituted 11-phenyl-dibenzazepine compounds useful for the treatment or prevention of diseases characterized by abnormal cell proliferation'20066,800,658'Substituted diphenyl indanone, indane and indole compounds and analogues thereof useful for the treatment of prevention of diseases characterized by abnormal cell proliferation'20046,752,929'Methods of separating FTC isomers and derivatives thereof'20046,541,631'Methods of separating FTC isomers and derivatives thereof'20036,534,497'Substitute 11-phenyl-dibenzazepine compounds useful for the treatment or prevention of diseases characterized by abnormal cell proliferation'20036,462,221'Synthesis of nitroalcohol diastereomers'20026,331,564'Use of triaryl methane compounds for inhibiting unwanted cellular proliferation associated with inflammatory disease'20016,268,535'Synthesis of 3-aryl-1-indanamines'20016,201,120'Synthesis of 11-aryl-5,6-dihydro-11H-dibenz[b,e]azepines'20016,127,407'Substituted diphenyl indanone, indane and indole compounds and analogues thereof useful for the treatment of prevention of diseases characterized by abnormal cell proliferation'20006,063,921'Synthesis of 11-aryl-5,6-dihydro-11H-dibenz[b,e]azepines'20006,043,272'Substituted diphenyl indanone, indane and indole compounds and analogues thereof useful for the treatment of prevention of diseases characterized by abnormal cell proliferation'20006,028,103'Triaryl methane compounds and analogues thereof useful for the treatment or prevention of sickle cell disease or diseases characterized by abnormal cell proliferation'2000Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2000–2009Patents assigned to CHILDRENS MEDICAL CENTER (5)· patent assignee history
2000–2020Based in Burlington, MA, US· patent location history
2008–2016Patents assigned to IDENIX PHARMACEUTICALS INC (12)· patent assignee history
2015–2020Patents assigned to IDENIX PHARMACEUTICALS LLC (11)· patent assignee history
2015–2019Patents assigned to CENTRE NAT RECH SCIENT (5)· patent assignee history
2017–2020Patents assigned to ATEA PHARMACEUTICALS INC (12)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| ATEA PHARMACEUTICALS INC | 12 | 2017–2020 |
| IDENIX PHARMACEUTICALS INC | 12 | 2008–2016 |
| IDENIX PHARMACEUTICALS LLC | 11 | 2015–2020 |
| CENTRE NAT RECH SCIENT | 5 | 2015–2019 |
| CHILDRENS MEDICAL CENTER | 5 | 2000–2009 |
Locations
| Location | Patents | Span |
|---|---|---|
| Burlington, Massachusetts, US | 48 | 2000–2020 |